Furthermore, previous attempts have been made to restore expression of mutant nephrin proteins on the surface using a chemical chaperone approach [38], and our studies suggest that preserving nephrin phosphorylation may represent a novel therapeutic strategy for glomerular disease. This evidence concerns the gene NPHS1 and glomerular disorder.